Lenvima 14 MG daily dose 60S
Ended Awarded
- Contract number
- SPE2DB25FQWPP
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,354
Award facts
- Contract value 100% obligated
- $11,353.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 10, 2025, by the Defense Logistics Agency for the supply of Lenvima 14 mg daily dose medication in quantities of 60 units. This firm fixed-price delivery order, valued at $11,353.77, is scheduled for completion by October 1, 2025, with no set-aside designation applied. The award represents a continuation of DMS Pharmaceutical Group's extensive relationship with the DLA, through which the company serves as a critical supplier of pharmaceutical products to military and federal healthcare facilities nationwide.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.99 billion contract vehicle valid through November 2026. The IDC enables the agency to issue firm fixed-price orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, biologics, and medical consumables supporting the medical supply needs of Department of Defense healthcare sites globally. Lenvima, an oncology treatment medication, aligns with the company's demonstrated capabilities in supplying specialized pharmaceutical products to federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FQWPP?
SPE2DB25FQWPP was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FQWPP worth?
The government has obligated $11,354 on SPE2DB25FQWPP.
Is contract SPE2DB25FQWPP an order under another contract?
Yes. SPE2DB25FQWPP is a delivery order under SPE2DB25D9321, an indefinite delivery contract.
Was contract SPE2DB25FQWPP competed?
The extent of competition for SPE2DB25FQWPP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award